Operation Re:Comp (Ostarine + Cardarine) – Product Information
Operation Re:Comp is a powerful combination of Ostarine and Cardarine. This combination brings together the potential research benefits of these compounds. Ostarine, known for its potential muscle-building properties, and Cardarine, recognized for its potential endurance-enhancing effects, may work synergistically to aid researchers in exploring various potential applications.
- Operation Re:Comp consist of two compounds: Ostarine and Cardarine.
- Ostarine is offered in 33mg per ml for 30ml, totaling 1000mg.
- Cardarine is offered in 33mg per ml for 30ml, totaling 1000mg.
Ostarine, also known as MK-2866, is currently one of the best research compounds focused on cutting. Initially, however, Ostarine was created to help fight muscle-wasting diseases. According to research, it selectively binds to androgen receptors in the body and displays beneficial effects on muscle structure and metabolism in ovariectomized rats. Ostarine also displayed improved muscle vascularization in ovariectomized rats. This yields massive potential in the field of research to further investigate the possibility of preserving lean muscle tissue during a caloric deficit.
Cardarine, also known as GW-501516, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week treatment with GW501516 increased the running performance of both trained and untrained mice. Like training, GW501516 promoted mitochondrial fatty acid oxidation and increased fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, and resulting in increased fat loss.